There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Quoin Pharmaceuticals (QNRX – Research Report) and Omega Therapeutics (OMGA – Research Report) with bullish sentiments.
Quoin Pharmaceuticals (QNRX)
In a report released yesterday, Naz Rahman from Maxim Group maintained a Buy rating on Quoin Pharmaceuticals. The company’s shares closed last Wednesday at $0.55.
According to TipRanks.com, Rahman is ranked 0 out of 5 stars with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Quoin Pharmaceuticals.
See the top stocks recommended by analysts >>
Omega Therapeutics (OMGA)
In a report released today, Keay Nakae from Chardan Capital reiterated a Buy rating on Omega Therapeutics, with a price target of $12.00. The company’s shares closed last Wednesday at $6.43.
According to TipRanks.com, Nakae is a 3-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Omega Therapeutics with a $13.67 average price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on QNRX:
